Medical Industry News

By now, you’ve ogled at and interpreted several charts, graphs, all relating to COVID-19, especially those talking about flattening the curve.

In simple terms to flatten the curve of a disease means trying to ensure that there is a delay in contagion from one person to another – and slow down the spread of a virus to tackle it patient to patient. If all people get sick at the same time there will not be enough hospital beds to save them.

By wearing masks and other PPE, practicing social distancing, the virus has a lower chance of succeeding and infecting others. Hence the curve starts to flatten.

Several states across the U.S. have started reopening the economy, which means in order to truly follow the guidelines given by the CDC on flattening the curve – everyone should be wearing a mask and practicing social distancing to avoid spread of the coronavirus.

Back orders and allocations are inevitable in any industry, and especially susceptible in the medical industry. With such a high demand for supplies, manufacturers either do not make a sufficient amount of products to match the rising number of sales or distributors warehouses underpredict how much stock would be needed.

Sometimes, unforeseen natural disasters occur, leaving manufacturers and distributors without the opportunity to fulfill any orders. In 2018, there was an IV bag shortage due to Hurricane Maria in Puerto Rico; the Hurricane “amplified the IV bag shortage, in particular, sodium chloride 0.9% injection bags, which are ubiquitous in medical facilities and hospitals”.

As a result, clients (in our case, physician offices, surgery centers, medical spas, biological laboratories) were left at large, scrambling to find any distributor with remaining stock to avoid disruptions in procedures.